The study also evaluated whether TNF-α or IL-1β could be prognostic markers and evaluated whether increasing severity of COPD is associated with increasing levels of these novel biomarkers, which could be a useful adjunct to spirometry or in subjects unable to perform spirometry, this could be a useful surrogate. This evidence concerns the gene TNF and chronic obstructive pulmonary disease.